A Estenose do idoso

Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis

https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.119.040679

Muitos estudos e poucas respostas claras sobre a estenose mitral do idoso

Estenose subvalvar

Exemplo no webinar do uso de Ecoestresse em bicicleta para definir causa de dispneia em paciente com estenose mitral leve a moderada

Casos assim, vasculhe o subvalvar com muita atenção e 3D, se disponível!

Quimioterapia é vigilância

https://www.sciencedirect.com/science/article/pii/S1936878X18304479?via%3Dihub

.

Conclusions

A decrease in LV mass after anthracycline therapy may result from cardiomyocyte atrophy, demonstrating that mechanisms other than interstitial fibrosis and edema can raise ECV. The loss of LV cardiomyocyte mass increased with the degree of cardiomyocyte injury, assessed by peak cardiac troponin T after anthracycline treatment.

Nós ajudamos a RM.

Mas só de vez em quando!!!

Rsrs

Ecocardiografia ajuda sempre!

https://onlinelibrary.wiley.com/doi/full/10.1111/echo.14825

Results

Altogether, 45 patients were evaluated. The mean age was 61.4 ± 12.2 years. Hypertension (n = 29, 64%) and diabetes mellitus (n = 25, 55%) were the most common comorbidities followed by congestive heart failure (n = 11, 24%), coronary artery disease (n = 9, 20%), and valvular heart disease (n = 3, 7%). Eight patients (18%) showed evidence of myocardial injury, as suggested by elevated troponin levels. Brain natriuretic peptide was elevated in 14 patients (36%), and 14 patients had left ventricular dysfunction in the form of reduced ejection fraction (31%). Right ventricular (RV) dilatation was observed in six patients, and five patients had reduced RV ejection fraction. RV pressure and volume overload were observed in three patients. RV thrombus was observed in one patient. Pulmonary pressure was elevated in 10 patients (24%).

Conclusion

Two‐dimensional echocardiography can be an important bedside tool for the assessment of cardiovascular abnormalities and hemodynamic status of COVID‐19 patients.